DVAX
Price
$12.85
Change
-$0.02 (-0.16%)
Updated
Apr 3 closing price
Capitalization
1.62B
27 days until earnings call
RDHL
Price
$2.26
Change
-$0.19 (-7.76%)
Updated
Apr 3 closing price
Capitalization
15.74M
39 days until earnings call
Ad is loading...

DVAX vs RDHL

Header iconDVAX vs RDHL Comparison
Open Charts DVAX vs RDHLBanner chart's image
Dynavax Technologies
Price$12.85
Change-$0.02 (-0.16%)
Volume$2.53M
Capitalization1.62B
Redhill Biopharma
Price$2.26
Change-$0.19 (-7.76%)
Volume$43.02K
Capitalization15.74M
DVAX vs RDHL Comparison Chart
Loading...
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DVAX vs. RDHL commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DVAX is a Hold and RDHL is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (DVAX: $12.85 vs. RDHL: $2.26)
Brand notoriety: DVAX and RDHL are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: DVAX: 111% vs. RDHL: 37%
Market capitalization -- DVAX: $1.62B vs. RDHL: $15.74M
DVAX [@Pharmaceuticals: Other] is valued at $1.62B. RDHL’s [@Pharmaceuticals: Other] market capitalization is $15.74M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DVAX’s FA Score shows that 0 FA rating(s) are green whileRDHL’s FA Score has 0 green FA rating(s).

  • DVAX’s FA Score: 0 green, 5 red.
  • RDHL’s FA Score: 0 green, 5 red.
According to our system of comparison, DVAX is a better buy in the long-term than RDHL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DVAX’s TA Score shows that 5 TA indicator(s) are bullish while RDHL’s TA Score has 4 bullish TA indicator(s).

  • DVAX’s TA Score: 5 bullish, 4 bearish.
  • RDHL’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both DVAX and RDHL are a good buy in the short-term.

Price Growth

DVAX (@Pharmaceuticals: Other) experienced а -6.34% price change this week, while RDHL (@Pharmaceuticals: Other) price change was -17.82% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -4.00%. For the same industry, the average monthly price growth was -2.21%, and the average quarterly price growth was -10.30%.

Reported Earning Dates

DVAX is expected to report earnings on May 01, 2025.

RDHL is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-4.00% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DVAX($1.62B) has a higher market cap than RDHL($15.7M). DVAX YTD gains are higher at: 0.626 vs. RDHL (-63.607). RDHL has higher annual earnings (EBITDA): 52.8M vs. DVAX (9.67M). DVAX has more cash in the bank: 742M vs. RDHL (7.01M). RDHL has less debt than DVAX: RDHL (2.28M) vs DVAX (257M). DVAX has higher revenues than RDHL: DVAX (232M) vs RDHL (35.7M).
DVAXRDHLDVAX / RDHL
Capitalization1.62B15.7M10,325%
EBITDA9.67M52.8M18%
Gain YTD0.626-63.607-1%
P/E Ratio31.63N/A-
Revenue232M35.7M650%
Total Cash742M7.01M10,579%
Total Debt257M2.28M11,252%
FUNDAMENTALS RATINGS
DVAX vs RDHL: Fundamental Ratings
DVAX
RDHL
OUTLOOK RATING
1..100
853
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
47100
SMR RATING
1..100
84100
PRICE GROWTH RATING
1..100
5296
P/E GROWTH RATING
1..100
9673
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DVAX's Valuation (73) in the Biotechnology industry is in the same range as RDHL (84). This means that DVAX’s stock grew similarly to RDHL’s over the last 12 months.

DVAX's Profit vs Risk Rating (47) in the Biotechnology industry is somewhat better than the same rating for RDHL (100). This means that DVAX’s stock grew somewhat faster than RDHL’s over the last 12 months.

DVAX's SMR Rating (84) in the Biotechnology industry is in the same range as RDHL (100). This means that DVAX’s stock grew similarly to RDHL’s over the last 12 months.

DVAX's Price Growth Rating (52) in the Biotechnology industry is somewhat better than the same rating for RDHL (96). This means that DVAX’s stock grew somewhat faster than RDHL’s over the last 12 months.

RDHL's P/E Growth Rating (73) in the Biotechnology industry is in the same range as DVAX (96). This means that RDHL’s stock grew similarly to DVAX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DVAXRDHL
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
72%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
72%
Bullish Trend 1 day ago
70%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 11 days ago
77%
Bullish Trend 15 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ISCWX79.73N/A
N/A
Voya Multi-Manager International Sm Cp W
HGHYX43.15N/A
N/A
Hartford Healthcare Y
HCAIX94.26N/A
N/A
Harbor Capital Appreciation Inv
GEMUX23.81N/A
N/A
Goldman Sachs Emerging Markets Eq R6
PJDZX17.18N/A
N/A
PGIM Jennison Rising Dividend Z

DVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, DVAX has been loosely correlated with ACET. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if DVAX jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVAX
1D Price
Change %
DVAX100%
-0.16%
ACET - DVAX
39%
Loosely correlated
-7.32%
SNDL - DVAX
35%
Loosely correlated
-1.39%
SUPN - DVAX
29%
Poorly correlated
-1.01%
ETON - DVAX
27%
Poorly correlated
-5.73%
ALKS - DVAX
25%
Poorly correlated
-3.03%
More

RDHL and

Correlation & Price change

A.I.dvisor tells us that RDHL and EOLS have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RDHL and EOLS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDHL
1D Price
Change %
RDHL100%
-7.76%
EOLS - RDHL
30%
Poorly correlated
-6.79%
ACET - RDHL
27%
Poorly correlated
-7.32%
PTPI - RDHL
26%
Poorly correlated
-4.86%
SNOA - RDHL
23%
Poorly correlated
-2.31%
DVAX - RDHL
23%
Poorly correlated
-0.16%
More